151 related articles for article (PubMed ID: 38573528)
21. Regulator of differentiation 1 (ROD1) binds to the amphipathic C-terminal peptide of thrombospondin-4 and is involved in its mitogenic activity.
Sadvakassova G; Dobocan MC; Difalco MR; Congote LF
J Cell Physiol; 2009 Sep; 220(3):672-9. PubMed ID: 19441079
[TBL] [Abstract][Full Text] [Related]
22. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
23. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.
Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L
BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441
[TBL] [Abstract][Full Text] [Related]
24. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
[TBL] [Abstract][Full Text] [Related]
25. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y
Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of ROD1 inhibits invasion of breast cancer cells by suppressing the translocation of β-catenin into the nucleus.
Zhou Y; Zou H; Wu E; Huang L; Yin R; Mei Y; Zhu X
Oncol Lett; 2018 Aug; 16(2):2645-2653. PubMed ID: 30013660
[TBL] [Abstract][Full Text] [Related]
27. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of the m
Li X; Yang Y; Chen Z
Metabolism; 2023 Jan; 138():155339. PubMed ID: 36302453
[TBL] [Abstract][Full Text] [Related]
29. YTHDC1 maintains trophoblasts function by promoting degradation of m6A-modified circMPP1.
Wang D; Guan H; Xia Y
Biochem Pharmacol; 2023 Apr; 210():115456. PubMed ID: 36780989
[TBL] [Abstract][Full Text] [Related]
30. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
31. N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export.
Xu P; Yang J; Chen Z; Zhang X; Xia Y; Wang S; Wang W; Xu Z
Cancer Commun (Lond); 2023 Jun; 43(6):685-705. PubMed ID: 37256823
[TBL] [Abstract][Full Text] [Related]
32. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.
Li W; Ye K; Li X; Liu X; Peng M; Chen F; Xiong W; Wang Y; Zhu L
J Exp Clin Cancer Res; 2022 Aug; 41(1):250. PubMed ID: 35974388
[TBL] [Abstract][Full Text] [Related]
33. The multifaceted effects of YTHDC1-mediated nuclear m
Widagdo J; Anggono V; Wong JJ
Trends Genet; 2022 Apr; 38(4):325-332. PubMed ID: 34920906
[TBL] [Abstract][Full Text] [Related]
34. Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing.
Roundtree IA; He C
Trends Genet; 2016 Jun; 32(6):320-321. PubMed ID: 27050931
[TBL] [Abstract][Full Text] [Related]
35. YTHDC1 mediates nuclear export of N
Roundtree IA; Luo GZ; Zhang Z; Wang X; Zhou T; Cui Y; Sha J; Huang X; Guerrero L; Xie P; He E; Shen B; He C
Elife; 2017 Oct; 6():. PubMed ID: 28984244
[No Abstract] [Full Text] [Related]
36. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
[TBL] [Abstract][Full Text] [Related]
37. Chromatin-associated YTHDC1 coordinates heat-induced reprogramming of gene expression.
Timcheva K; Dufour S; Touat-Todeschini L; Burnard C; Carpentier MC; Chuffart F; Merret R; Helsmoortel M; Ferré S; Grézy A; Couté Y; Rousseaux S; Khochbin S; Vourc'h C; Bousquet-Antonelli C; Kiernan R; Seigneurin-Berny D; Verdel A
Cell Rep; 2022 Dec; 41(11):111784. PubMed ID: 36516773
[TBL] [Abstract][Full Text] [Related]
38. Alternative Splicing Factor Heterogeneous Nuclear Ribonucleoprotein U as a Promising Biomarker for Gastric Cancer Risk and Prognosis with Tumor-Promoting Properties.
Dong YY; Wang MY; Jing JJ; Wu YJ; Li H; Yuan Y; Sun LP
Am J Pathol; 2024 Jan; 194(1):13-29. PubMed ID: 37923250
[TBL] [Abstract][Full Text] [Related]
39. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
40. Structural effects of m6A modification of the Xist A-repeat AUCG tetraloop and its recognition by YTHDC1.
Jones AN; Tikhaia E; Mourão A; Sattler M
Nucleic Acids Res; 2022 Feb; 50(4):2350-2362. PubMed ID: 35166835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
